These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Co-administration of the adjuvanted recombinant zoster vaccine with other adult vaccines: An overview. Ali SO; Dessart C; Parikh R Vaccine; 2024 Mar; 42(8):2026-2035. PubMed ID: 38423814 [TBL] [Abstract][Full Text] [Related]
46. Public Health Impact and Cost-Effectiveness of Non-live Adjuvanted Recombinant Zoster Vaccine in Canadian Adults. McGirr A; Van Oorschot D; Widenmaier R; Stokes M; Ganz ML; Jung H; Varghese L; Curran D Appl Health Econ Health Policy; 2019 Oct; 17(5):723-732. PubMed ID: 31250218 [TBL] [Abstract][Full Text] [Related]
47. Completion of the two-dose recombinant zoster vaccine series in adults 50 years and older. Ackerson B; Qian L; Sy LS; Bruxvoort K; Wu J; Luo Y; Diaz-Decaro J; Talarico C; Tseng HF Vaccine; 2021 Feb; 39(6):926-932. PubMed ID: 33441234 [TBL] [Abstract][Full Text] [Related]
48. Review of the initial post-marketing safety surveillance for the recombinant zoster vaccine. Tavares-Da-Silva F; Co MM; Dessart C; Hervé C; López-Fauqued M; Mahaux O; Van Holle L; Stegmann JU Vaccine; 2020 Apr; 38(18):3489-3500. PubMed ID: 31818534 [TBL] [Abstract][Full Text] [Related]
49. Immunogenicity and influence on disease activity of recombinant zoster vaccine in patients with rheumatoid arthritis treated with DMARDs. Kojima S; Iwamoto T; Kobayashi Y; Kato M; Takizawa F; Ida T; Suzuki J; Toda Y; Miyachi K; Iwata A; Furuta S; Ikeda K; Nakajima H RMD Open; 2024 Feb; 10(1):. PubMed ID: 38388170 [TBL] [Abstract][Full Text] [Related]
51. Cost-effectiveness of an Adjuvanted Recombinant Zoster Vaccine in older adults in the United States. Curran D; Patterson B; Varghese L; Van Oorschot D; Buck P; Carrico J; Hicks K; Lee B; Yawn B Vaccine; 2018 Aug; 36(33):5037-5045. PubMed ID: 30017145 [TBL] [Abstract][Full Text] [Related]
52. The adjuvanted recombinant zoster vaccine co-administered with a tetanus, diphtheria and pertussis vaccine in adults aged ≥50 years: A randomized trial. Strezova A; Lal H; Enweonye I; Campora L; Beukelaers P; Segall N; Heineman TC; Schuind AE; Oostvogels L Vaccine; 2019 Sep; 37(39):5877-5885. PubMed ID: 31443993 [TBL] [Abstract][Full Text] [Related]
53. Comparative Antibody Responses to the Live-Attenuated and Recombinant Herpes Zoster Vaccines. Schmid DS; Miao C; Leung J; Johnson M; Weinberg A; Levin MJ J Virol; 2021 May; 95(12):. PubMed ID: 33762414 [TBL] [Abstract][Full Text] [Related]
54. Survey of Physician Practices, Attitudes, and Knowledge Regarding Recombinant Zoster Vaccine. Hurley LP; O'Leary ST; Dooling K; Anderson TC; Crane LA; Cataldi JR; Brtnikova M; Beaty BL; Gorman C; Guo A; Lindley MC; Kempe A J Gen Intern Med; 2023 Mar; 38(4):986-993. PubMed ID: 35794307 [TBL] [Abstract][Full Text] [Related]
55. Recombinant Zoster Vaccine Is Efficacious and Safe in Frail Individuals. Curran D; Kim JH; Matthews S; Dessart C; Levin MJ; Oostvogels L; Riley ME; Schmader KE; Cunningham AL; McNeil SA; Schuind AE; Andrew MK; J Am Geriatr Soc; 2021 Mar; 69(3):744-752. PubMed ID: 33197294 [TBL] [Abstract][Full Text] [Related]
56. Primary care physicians' experience with zoster vaccine live (ZVL) and awareness and attitudes regarding the new recombinant zoster vaccine (RZV). Hurley LP; Allison MA; Dooling KL; O'Leary ST; Crane LA; Brtnikova M; Beaty BL; Allen JA; Guo A; Lindley MC; Kempe A Vaccine; 2018 Nov; 36(48):7408-7414. PubMed ID: 30420121 [TBL] [Abstract][Full Text] [Related]
57. Annual incidence rates of herpes zoster among an immunocompetent population in the United States. Johnson BH; Palmer L; Gatwood J; Lenhart G; Kawai K; Acosta CJ BMC Infect Dis; 2015 Nov; 15():502. PubMed ID: 26546419 [TBL] [Abstract][Full Text] [Related]
58. Efficacy and serious adverse events profile of the adjuvanted recombinant zoster vaccine in adults with pre-existing potential immune-mediated diseases: a pooled post hoc analysis on two parallel randomized trials. Dagnew AF; Rausch D; Hervé C; Zahaf T; Levin MJ; Schuind A; Rheumatology (Oxford); 2021 Mar; 60(3):1226-1233. PubMed ID: 32910152 [TBL] [Abstract][Full Text] [Related]